MGRX
Mangoceuticals, Inc. Common Stock
NASDAQ: MGRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$0.34
+2.56% today
Updated 2026-04-30
Market cap
$6.79M
P/E ratio
—
P/S ratio
14.88x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$0 – $3
Volume
15.5M
Mangoceuticals, Inc. Common Stock (MGRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $22550.00 | $1.00M | $1.05M | $15.37M |
| Cash & equivalents | $22550.00 | $682860.00 | $739006.00 | $58653.00 |
| Current assets | $22550.00 | $694605.00 | $818460.00 | $75595.00 |
| Total liabilities | $39270.00 | $389257.00 | $276039.00 | $1.43M |
| Current liabilities | $39270.00 | $260577.00 | $211078.00 | $1.43M |
| Long-term debt | — | — | — | — |
| Shareholder equity | $-16720.00 | $614030.00 | $774754.00 | $13.95M |
| Retained earnings | $-17701.00 | $-2.02M | $-11.23M | $-20.81M |
| Accounts receivable | — | — | $0.00 | — |
| Inventory | — | $0.00 | $18501.00 | $0.00 |
| Goodwill | — | — | — | — |